 Stephen Duntley
Concepts (250)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Polysomnography | 15 | 2018 | 185 | 1.490 |
Why?
| | Electroencephalography | 8 | 2014 | 423 | 1.040 |
Why?
| | Sleep Apnea, Obstructive | 11 | 2018 | 293 | 1.020 |
Why?
| | Restless Legs Syndrome | 3 | 2012 | 21 | 0.990 |
Why?
| | REM Sleep Behavior Disorder | 2 | 2011 | 14 | 0.720 |
Why?
| | Electrocardiography | 3 | 2018 | 629 | 0.680 |
Why?
| | Sleep Apnea Syndromes | 5 | 2015 | 88 | 0.660 |
Why?
| | Sleep, REM | 5 | 2011 | 33 | 0.640 |
Why?
| | Antidepressive Agents | 2 | 2011 | 236 | 0.620 |
Why?
| | Neurodegenerative Diseases | 2 | 2011 | 135 | 0.610 |
Why?
| | Sleep | 7 | 2011 | 755 | 0.570 |
Why?
| | Sleep Wake Disorders | 3 | 2013 | 286 | 0.560 |
Why?
| | Autoimmune Diseases | 2 | 2011 | 460 | 0.530 |
Why?
| | Epilepsy | 2 | 2011 | 333 | 0.520 |
Why?
| | Sleep Deprivation | 5 | 2013 | 174 | 0.510 |
Why?
| | Sleep Stages | 4 | 2018 | 47 | 0.490 |
Why?
| | Arousal | 3 | 2011 | 155 | 0.420 |
Why?
| | Drosophila Proteins | 2 | 2012 | 204 | 0.410 |
Why?
| | Disorders of Excessive Somnolence | 5 | 2015 | 32 | 0.360 |
Why?
| | Sleep Apnea, Central | 1 | 2011 | 10 | 0.350 |
Why?
| | Myoclonus | 1 | 2011 | 15 | 0.350 |
Why?
| | Autonomic Nervous System Diseases | 1 | 2011 | 36 | 0.350 |
Why?
| | Iron | 1 | 2012 | 313 | 0.320 |
Why?
| | Coronary Disease | 3 | 2007 | 385 | 0.320 |
Why?
| | Cerebral Cortex | 3 | 2014 | 433 | 0.320 |
Why?
| | Dopamine | 1 | 2012 | 303 | 0.310 |
Why?
| | Heart Rate | 4 | 2007 | 822 | 0.300 |
Why?
| | Carrier Proteins | 1 | 2012 | 771 | 0.280 |
Why?
| | Irritable Bowel Syndrome | 1 | 2007 | 28 | 0.270 |
Why?
| | Celiac Disease | 1 | 2010 | 294 | 0.260 |
Why?
| | Status Epilepticus | 1 | 2007 | 50 | 0.260 |
Why?
| | Oxygen | 2 | 2011 | 931 | 0.260 |
Why?
| | Intestine, Small | 1 | 2007 | 156 | 0.250 |
Why?
| | Fibrinogen | 1 | 2007 | 168 | 0.250 |
Why?
| | Sleep Initiation and Maintenance Disorders | 4 | 2013 | 165 | 0.250 |
Why?
| | Clonazepam | 1 | 2004 | 5 | 0.230 |
Why?
| | Depressive Disorder | 2 | 2006 | 379 | 0.230 |
Why?
| | Diagnosis, Computer-Assisted | 1 | 2004 | 89 | 0.220 |
Why?
| | Inflammation Mediators | 1 | 2007 | 513 | 0.210 |
Why?
| | Depression | 3 | 2007 | 1397 | 0.200 |
Why?
| | Models, Animal | 1 | 2004 | 384 | 0.200 |
Why?
| | Middle Aged | 21 | 2018 | 33479 | 0.190 |
Why?
| | Continuous Positive Airway Pressure | 4 | 2014 | 83 | 0.190 |
Why?
| | Brain | 2 | 2012 | 2668 | 0.190 |
Why?
| | Cardiac Pacing, Artificial | 1 | 2002 | 87 | 0.190 |
Why?
| | Seizures | 1 | 2004 | 426 | 0.180 |
Why?
| | Aged | 14 | 2018 | 23961 | 0.170 |
Why?
| | Somatosensory Cortex | 1 | 2001 | 35 | 0.170 |
Why?
| | Adult | 21 | 2018 | 37929 | 0.170 |
Why?
| | Humans | 39 | 2018 | 137585 | 0.160 |
Why?
| | Female | 27 | 2018 | 73304 | 0.160 |
Why?
| | Male | 25 | 2018 | 67762 | 0.160 |
Why?
| | Prevalence | 5 | 2013 | 2734 | 0.140 |
Why?
| | Comorbidity | 4 | 2013 | 1622 | 0.130 |
Why?
| | Saliva | 2 | 2015 | 242 | 0.120 |
Why?
| | Sodium Oxybate | 1 | 2014 | 4 | 0.110 |
Why?
| | Epilepsy, Absence | 1 | 2014 | 9 | 0.110 |
Why?
| | Sensitivity and Specificity | 2 | 2018 | 1946 | 0.110 |
Why?
| | Cyclooxygenase 2 | 1 | 2015 | 178 | 0.110 |
Why?
| | Risk Factors | 8 | 2013 | 10388 | 0.110 |
Why?
| | Incidence | 2 | 2011 | 2804 | 0.100 |
Why?
| | C-Reactive Protein | 2 | 2007 | 410 | 0.100 |
Why?
| | Drosophila | 2 | 2013 | 154 | 0.100 |
Why?
| | Narcolepsy | 2 | 2011 | 21 | 0.100 |
Why?
| | Benzhydryl Compounds | 1 | 2014 | 73 | 0.100 |
Why?
| | Amyloid beta-Peptides | 2 | 2013 | 220 | 0.100 |
Why?
| | Surveys and Questionnaires | 4 | 2011 | 5778 | 0.100 |
Why?
| | Circadian Rhythm | 5 | 2011 | 468 | 0.090 |
Why?
| | Plaque, Amyloid | 1 | 2011 | 15 | 0.090 |
Why?
| | Algorithms | 2 | 2018 | 1704 | 0.090 |
Why?
| | Central Nervous System | 2 | 2011 | 258 | 0.090 |
Why?
| | Memory, Short-Term | 1 | 2014 | 250 | 0.090 |
Why?
| | Somnambulism | 1 | 2011 | 1 | 0.090 |
Why?
| | Chromosomes, Human, Pair 9 | 1 | 2011 | 41 | 0.090 |
Why?
| | Chromosome Inversion | 1 | 2011 | 18 | 0.090 |
Why?
| | Antiparkinson Agents | 1 | 2011 | 27 | 0.090 |
Why?
| | Cyclohexanecarboxylic Acids | 1 | 2011 | 22 | 0.090 |
Why?
| | Diphenhydramine | 1 | 2011 | 37 | 0.090 |
Why?
| | Amines | 1 | 2011 | 40 | 0.090 |
Why?
| | Statistics as Topic | 3 | 2007 | 307 | 0.090 |
Why?
| | Chromosome Disorders | 1 | 2011 | 43 | 0.090 |
Why?
| | Amyloid | 1 | 2011 | 87 | 0.090 |
Why?
| | Chromosomes, Human, X | 1 | 2011 | 73 | 0.090 |
Why?
| | Receptors, Notch | 1 | 2011 | 88 | 0.080 |
Why?
| | Chromosomes | 1 | 2011 | 107 | 0.080 |
Why?
| | Oximetry | 1 | 2011 | 96 | 0.080 |
Why?
| | Genetic Linkage | 1 | 2011 | 297 | 0.080 |
Why?
| | Diet, Gluten-Free | 1 | 2010 | 45 | 0.080 |
Why?
| | Age Distribution | 1 | 2011 | 392 | 0.080 |
Why?
| | Sex Distribution | 1 | 2011 | 375 | 0.080 |
Why?
| | Family Health | 1 | 2011 | 196 | 0.080 |
Why?
| | Pedigree | 1 | 2011 | 514 | 0.080 |
Why?
| | Cardiovascular Diseases | 2 | 2013 | 2111 | 0.080 |
Why?
| | Anemia, Iron-Deficiency | 1 | 2010 | 58 | 0.080 |
Why?
| | Interleukin-6 | 3 | 2013 | 778 | 0.080 |
Why?
| | gamma-Aminobutyric Acid | 1 | 2011 | 198 | 0.080 |
Why?
| | Intellectual Disability | 1 | 2011 | 165 | 0.080 |
Why?
| | Age of Onset | 1 | 2011 | 518 | 0.080 |
Why?
| | Drosophila melanogaster | 2 | 2011 | 233 | 0.080 |
Why?
| | Chi-Square Distribution | 1 | 2010 | 530 | 0.080 |
Why?
| | Hypnotics and Sedatives | 1 | 2011 | 200 | 0.070 |
Why?
| | Treatment Outcome | 5 | 2014 | 10811 | 0.070 |
Why?
| | Postoperative Complications | 2 | 2013 | 2654 | 0.070 |
Why?
| | Neuromuscular Diseases | 1 | 2010 | 132 | 0.070 |
Why?
| | Rifamycins | 1 | 2007 | 5 | 0.070 |
Why?
| | Serotonin Receptor Agonists | 1 | 2007 | 26 | 0.070 |
Why?
| | Epilepsy, Complex Partial | 1 | 2007 | 3 | 0.070 |
Why?
| | Epilepsy, Tonic-Clonic | 1 | 2007 | 5 | 0.070 |
Why?
| | Case-Control Studies | 3 | 2011 | 3556 | 0.070 |
Why?
| | Sleep Disorders, Circadian Rhythm | 2 | 2007 | 50 | 0.070 |
Why?
| | Breath Tests | 1 | 2007 | 87 | 0.070 |
Why?
| | Odds Ratio | 1 | 2010 | 1070 | 0.070 |
Why?
| | Homeostasis | 1 | 2011 | 621 | 0.070 |
Why?
| | Gastrointestinal Agents | 1 | 2007 | 65 | 0.070 |
Why?
| | Retrospective Studies | 2 | 2018 | 15657 | 0.070 |
Why?
| | Diagnosis, Differential | 1 | 2011 | 1483 | 0.070 |
Why?
| | Adolescent | 4 | 2014 | 21513 | 0.070 |
Why?
| | Alzheimer Disease | 1 | 2013 | 560 | 0.070 |
Why?
| | Depressive Disorder, Major | 1 | 2011 | 364 | 0.070 |
Why?
| | Prospective Studies | 4 | 2014 | 7604 | 0.060 |
Why?
| | Autonomic Nervous System | 1 | 2007 | 75 | 0.060 |
Why?
| | Pregnancy Outcome | 1 | 2009 | 416 | 0.060 |
Why?
| | Gene Expression | 1 | 2011 | 1502 | 0.060 |
Why?
| | Biological Clocks | 1 | 2006 | 45 | 0.060 |
Why?
| | Heart Conduction System | 1 | 2006 | 99 | 0.060 |
Why?
| | Academic Medical Centers | 1 | 2009 | 512 | 0.060 |
Why?
| | Models, Cardiovascular | 1 | 2006 | 198 | 0.060 |
Why?
| | Pituitary Neoplasms | 1 | 2007 | 190 | 0.060 |
Why?
| | Fatigue | 2 | 2004 | 329 | 0.060 |
Why?
| | Severity of Illness Index | 4 | 2009 | 2828 | 0.060 |
Why?
| | Logistic Models | 1 | 2010 | 2074 | 0.060 |
Why?
| | Nocturnal Myoclonus Syndrome | 1 | 2004 | 5 | 0.060 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2007 | 1242 | 0.060 |
Why?
| | Drug Therapy, Combination | 1 | 2007 | 1066 | 0.060 |
Why?
| | Mass Screening | 1 | 2013 | 1287 | 0.060 |
Why?
| | Indoles | 1 | 2007 | 412 | 0.050 |
Why?
| | Pregnancy Complications | 1 | 2009 | 527 | 0.050 |
Why?
| | Personality Inventory | 1 | 2004 | 139 | 0.050 |
Why?
| | Arrhythmias, Cardiac | 1 | 2006 | 333 | 0.050 |
Why?
| | Animals | 7 | 2013 | 36940 | 0.050 |
Why?
| | Multiple Sclerosis, Chronic Progressive | 1 | 2004 | 28 | 0.050 |
Why?
| | Probability | 1 | 2004 | 304 | 0.050 |
Why?
| | Herpesviridae Infections | 1 | 2005 | 147 | 0.050 |
Why?
| | DNA-Binding Proteins | 1 | 2011 | 1502 | 0.050 |
Why?
| | Epstein-Barr Virus Infections | 1 | 2005 | 98 | 0.050 |
Why?
| | Learning | 2 | 2011 | 409 | 0.050 |
Why?
| | Rats | 3 | 2013 | 5647 | 0.050 |
Why?
| | Multiple Sclerosis, Relapsing-Remitting | 1 | 2004 | 76 | 0.050 |
Why?
| | Cytomegalovirus Infections | 1 | 2005 | 192 | 0.050 |
Why?
| | Electrocardiography, Ambulatory | 1 | 2003 | 63 | 0.050 |
Why?
| | Patient Compliance | 1 | 2007 | 581 | 0.050 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2011 | 2189 | 0.050 |
Why?
| | Rape | 1 | 2003 | 38 | 0.050 |
Why?
| | Disease Susceptibility | 1 | 2004 | 347 | 0.050 |
Why?
| | Anticonvulsants | 1 | 2004 | 217 | 0.050 |
Why?
| | Biomarkers | 5 | 2015 | 4149 | 0.050 |
Why?
| | Pilot Projects | 1 | 2007 | 1710 | 0.050 |
Why?
| | Body Mass Index | 2 | 2015 | 2389 | 0.050 |
Why?
| | Wakefulness | 3 | 2011 | 125 | 0.050 |
Why?
| | Magnetic Resonance Imaging | 1 | 2014 | 3566 | 0.050 |
Why?
| | Subdural Space | 1 | 2001 | 8 | 0.040 |
Why?
| | Signal Transduction | 2 | 2013 | 5079 | 0.040 |
Why?
| | Aging | 1 | 2011 | 1864 | 0.040 |
Why?
| | Risk Assessment | 1 | 2010 | 3457 | 0.040 |
Why?
| | Electrodes, Implanted | 1 | 2001 | 109 | 0.040 |
Why?
| | Postoperative Period | 2 | 2013 | 342 | 0.040 |
Why?
| | Health Status | 1 | 2004 | 792 | 0.040 |
Why?
| | Young Adult | 2 | 2014 | 13209 | 0.040 |
Why?
| | Intracellular Signaling Peptides and Proteins | 2 | 2011 | 455 | 0.040 |
Why?
| | Cognition Disorders | 1 | 2002 | 496 | 0.040 |
Why?
| | Central Nervous System Stimulants | 2 | 2011 | 161 | 0.030 |
Why?
| | Stress Disorders, Post-Traumatic | 1 | 2003 | 847 | 0.030 |
Why?
| | Gene Expression Profiling | 2 | 2013 | 1774 | 0.030 |
Why?
| | Hydroxybutyrates | 1 | 2014 | 14 | 0.030 |
Why?
| | Apoptosis | 1 | 2004 | 2553 | 0.030 |
Why?
| | Caspase 1 | 1 | 2015 | 144 | 0.030 |
Why?
| | Wakefulness-Promoting Agents | 1 | 2014 | 3 | 0.030 |
Why?
| | Anesthetics | 1 | 2014 | 81 | 0.030 |
Why?
| | Annexin A3 | 1 | 2013 | 1 | 0.030 |
Why?
| | RNA, Messenger | 2 | 2015 | 2833 | 0.030 |
Why?
| | Social Security | 1 | 2013 | 5 | 0.030 |
Why?
| | Prodromal Symptoms | 1 | 2013 | 15 | 0.030 |
Why?
| | CD11b Antigen | 1 | 2013 | 61 | 0.030 |
Why?
| | Circadian Clocks | 1 | 2013 | 50 | 0.020 |
Why?
| | Actigraphy | 1 | 2013 | 110 | 0.020 |
Why?
| | Time Factors | 3 | 2013 | 6828 | 0.020 |
Why?
| | Mushroom Bodies | 1 | 2011 | 4 | 0.020 |
Why?
| | Positive-Pressure Respiration | 2 | 2003 | 80 | 0.020 |
Why?
| | Caffeine | 1 | 2011 | 68 | 0.020 |
Why?
| | Receptor-Like Protein Tyrosine Phosphatases, Class 2 | 1 | 2011 | 10 | 0.020 |
Why?
| | DNA Topoisomerases, Type I | 1 | 2011 | 15 | 0.020 |
Why?
| | Thiazoles | 1 | 2011 | 123 | 0.020 |
Why?
| | Phospholipase C gamma | 1 | 2011 | 29 | 0.020 |
Why?
| | Aniline Compounds | 1 | 2011 | 102 | 0.020 |
Why?
| | Methamphetamine | 1 | 2011 | 63 | 0.020 |
Why?
| | Mutation | 2 | 2013 | 3958 | 0.020 |
Why?
| | Predictive Value of Tests | 2 | 2009 | 2031 | 0.020 |
Why?
| | Adenosine Deaminase | 1 | 2011 | 36 | 0.020 |
Why?
| | Video Recording | 1 | 2011 | 180 | 0.020 |
Why?
| | Kaplan-Meier Estimate | 1 | 2013 | 889 | 0.020 |
Why?
| | Microscopy, Confocal | 1 | 2011 | 325 | 0.020 |
Why?
| | Neuroglia | 1 | 2011 | 173 | 0.020 |
Why?
| | Positron-Emission Tomography | 1 | 2011 | 294 | 0.020 |
Why?
| | Peptide Fragments | 1 | 2013 | 706 | 0.020 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 852 | 0.020 |
Why?
| | Double-Blind Method | 1 | 2014 | 1993 | 0.020 |
Why?
| | Linear Models | 1 | 2011 | 849 | 0.020 |
Why?
| | Cross-Sectional Studies | 2 | 2013 | 5472 | 0.020 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2011 | 767 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2011 | 1316 | 0.020 |
Why?
| | Polymerase Chain Reaction | 1 | 2011 | 1062 | 0.020 |
Why?
| | Neoplasm Proteins | 1 | 2011 | 434 | 0.020 |
Why?
| | Depression, Postpartum | 1 | 2009 | 132 | 0.020 |
Why?
| | Cataplexy | 1 | 2007 | 6 | 0.020 |
Why?
| | Amylases | 1 | 2006 | 17 | 0.020 |
Why?
| | Phototherapy | 1 | 2007 | 39 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2011 | 1738 | 0.020 |
Why?
| | Transcription, Genetic | 1 | 2013 | 1457 | 0.020 |
Why?
| | Causality | 1 | 2007 | 126 | 0.020 |
Why?
| | Oscillometry | 1 | 2006 | 42 | 0.020 |
Why?
| | Nuclear Proteins | 1 | 2011 | 712 | 0.020 |
Why?
| | Aged, 80 and over | 2 | 2011 | 7635 | 0.020 |
Why?
| | Premature Birth | 1 | 2009 | 333 | 0.010 |
Why?
| | Feasibility Studies | 1 | 2009 | 956 | 0.010 |
Why?
| | Membrane Proteins | 1 | 2011 | 1164 | 0.010 |
Why?
| | Suprachiasmatic Nucleus | 1 | 2004 | 16 | 0.010 |
Why?
| | Clonidine | 1 | 2004 | 28 | 0.010 |
Why?
| | Statistics, Nonparametric | 1 | 2005 | 431 | 0.010 |
Why?
| | Genome-Wide Association Study | 1 | 2011 | 1431 | 0.010 |
Why?
| | Up-Regulation | 1 | 2006 | 843 | 0.010 |
Why?
| | Missouri | 1 | 2003 | 61 | 0.010 |
Why?
| | Neurons | 1 | 2011 | 1590 | 0.010 |
Why?
| | Computer Simulation | 1 | 2006 | 978 | 0.010 |
Why?
| | Sampling Studies | 1 | 2002 | 99 | 0.010 |
Why?
| | Inflammation | 1 | 2013 | 2837 | 0.010 |
Why?
| | Electromyography | 1 | 2004 | 400 | 0.010 |
Why?
| | Semantics | 1 | 2002 | 92 | 0.010 |
Why?
| | Leg | 1 | 2003 | 236 | 0.010 |
Why?
| | Health Behavior | 1 | 2007 | 762 | 0.010 |
Why?
| | Frontal Lobe | 1 | 2002 | 149 | 0.010 |
Why?
| | Sex Factors | 1 | 2006 | 2071 | 0.010 |
Why?
| | Otorhinolaryngologic Surgical Procedures | 1 | 2000 | 40 | 0.010 |
Why?
| | Diabetes Mellitus | 1 | 2009 | 1040 | 0.010 |
Why?
| | Stroke | 1 | 2009 | 1120 | 0.010 |
Why?
| | Memory | 1 | 2002 | 248 | 0.010 |
Why?
| | Hypertension | 1 | 2009 | 1295 | 0.010 |
Why?
| | Age Factors | 1 | 2006 | 3295 | 0.010 |
Why?
| | Neuropsychological Tests | 1 | 2002 | 1023 | 0.010 |
Why?
| | Pregnancy | 1 | 2009 | 6763 | 0.010 |
Why?
| | United States | 1 | 2013 | 14841 | 0.010 |
Why?
|
|
Duntley's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|